PriceTargets.com logo

Option Care Health - OPCH Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $37.17
  • Forecasted Upside: 24.93%
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$29.75 As of 11/30/2023 01:00 AM ET
▲ +0.01 (0.03%)

This chart shows the closing price for OPCH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Option Care Health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for OPCH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for OPCH

Analyst Price Target is $37.17
▲ +24.93% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Option Care Health in the last 3 months. The average price target is $37.17, with a high forecast of $44.00 and a low forecast of $32.50. The average price target represents a 24.93% upside from the last price of $29.75.

This chart shows the closing price for OPCH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 3 contributing investment analysts is to buy stock in Option Care Health. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/8/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/6/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/5/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/5/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/3/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/1/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/31/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/30/2023

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/26/2023Barrington ResearchLower TargetOutperform ➝ Outperform$41.00 ➝ $35.00Low
10/18/2023JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$46.00 ➝ $44.00Low
7/28/2023Barrington ResearchBoost TargetOutperform$34.00 ➝ $41.00Low
5/5/2023Deutsche Bank AktiengesellschaftLower Target$39.00 ➝ $32.50Low
5/5/2023Barrington ResearchLower Target$38.00 ➝ $34.00Low
2/27/2023Jefferies Financial GroupInitiated CoverageBuyLow
10/28/2022Barrington ResearchBoost TargetOutperform$37.00 ➝ $38.00Low
8/22/2022The Goldman Sachs GroupBoost TargetBuy$31.00 ➝ $40.00Low
7/28/2022Lake Street CapitalBoost Target$35.00 ➝ $45.00Low
7/28/2022Barrington ResearchBoost TargetOutperform$33.00 ➝ $37.00Low
4/29/2022Barrington ResearchBoost Target$31.00 ➝ $33.00Medium
4/29/2022Deutsche Bank AktiengesellschaftBoost Target$32.00 ➝ $39.00High
11/5/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$23.50 ➝ $32.00Medium
8/30/2021Lake Street CapitalBoost TargetBuy$27.00 ➝ $35.00Low
8/4/2021Barrington ResearchBoost TargetOutperform$24.00 ➝ $28.00High
8/3/2021Lake Street CapitalBoost TargetBuy$25.00 ➝ $27.00Low
7/19/2021The Goldman Sachs GroupUpgradeNeutral ➝ Buy$20.00 ➝ $25.00Low
3/12/2021Barrington ResearchUpgradeOutperform$19.00 ➝ $24.00High
3/12/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$22.00 ➝ $23.50High
1/25/2021Truist FinancialBoost Target$21.00 ➝ $25.00Low
1/22/2021Deutsche Bank AktiengesellschaftInitiated CoverageBuy$22.00Medium
1/11/2021JPMorgan Chase & Co.Initiated CoverageOverweight$21.00Low
12/15/2020The Goldman Sachs GroupInitiated CoverageNeutral$18.00Low
8/5/2020Barrington ResearchBoost TargetOutperform$17.00 ➝ $19.00High
7/21/2020SunTrust BanksBoost TargetBuy$18.00 ➝ $21.00High
6/24/2020Bank of AmericaInitiated CoverageBuy$18.00High
2/19/2020Lake Street CapitalBoost TargetBuy$18.00 ➝ $23.00High
1/6/2020William BlairInitiated CoverageOutperformLow
9/20/2019SunTrust BanksBoost TargetBuy$3.25 ➝ $4.25Low
5/3/2019Barrington ResearchReiterated RatingBuy$4.00Low
3/18/2019StephensDowngradeOverweight ➝ Equal Weight$2.51High
12/7/2018Lake Street CapitalBoost TargetBuy$4.50 ➝ $10.00Medium
(Data available from 11/30/2018 forward)

News Sentiment Rating

1.40 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 18 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/4/2023
  • 23 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/3/2023
  • 21 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/3/2023
  • 15 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/2/2023
  • 16 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
9/1/2023
  • 8 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/1/2023
  • 13 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/31/2023
  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/30/2023

Current Sentiment

  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Option Care Health logo
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and others; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
Read More

Today's Range

Now: $29.75
Low: $29.49
High: $30.01

50 Day Range

MA: $30.66
Low: $26.63
High: $34.02

52 Week Range

Now: $29.75
Low: $24.23
High: $35.74

Volume

2,802,220 shs

Average Volume

2,125,283 shs

Market Capitalization

$5.27 billion

P/E Ratio

21.10

Dividend Yield

N/A

Beta

1.2

Frequently Asked Questions

What sell-side analysts currently cover shares of Option Care Health?

The following Wall Street research analysts have issued research reports on Option Care Health in the last year: Barrington Research, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group Inc., and JPMorgan Chase & Co..
View the latest analyst ratings for OPCH.

What is the current price target for Option Care Health?

3 Wall Street analysts have set twelve-month price targets for Option Care Health in the last year. Their average twelve-month price target is $37.17, suggesting a possible upside of 24.2%. JPMorgan Chase & Co. has the highest price target set, predicting OPCH will reach $44.00 in the next twelve months. Deutsche Bank Aktiengesellschaft has the lowest price target set, forecasting a price of $32.50 for Option Care Health in the next year.
View the latest price targets for OPCH.

What is the current consensus analyst rating for Option Care Health?

Option Care Health currently has 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe OPCH will outperform the market and that investors should add to their positions of Option Care Health.
View the latest ratings for OPCH.

What other companies compete with Option Care Health?

Other companies that are similar to Option Care Health include Amedisys, Chemed, Addus HomeCare, Halozyme Therapeutics and Ascendis Pharma A/S. Learn More about companies similar to Option Care Health.

How do I contact Option Care Health's investor relations team?

Option Care Health's physical mailing address is 3000 Lakeside Dr. Suite 300N, Bannockburn IL, 60015. The company's listed phone number is (312) 940-2443 and its investor relations email address is investor.relations@optioncare.com. The official website for Option Care Health is www.optioncarehealth.com. Learn More about contacing Option Care Health investor relations.